Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Aging Clinical and Experimental Research|April 17, 2024
Combining Mini-Mental State Examination and Montreal Cognitive Assessment for assessing the clinical efficacy of cholinesterase inhibitors in mild Alzheimer's disease: a pilot studyGiovanna Furneri, Simone Varrasi, Claudia Savia Guerrera, et al.ACS Chemical Neuroscience|November 15, 2024
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic ActivityValeria Poggetti, Elisa Angeloni, Lorenzo Germelli, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2016
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluationM Florencia Iulita, Alison Ower, Concetta Barone, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2012
p300/CBP-associated factor selectively regulates the extinction of conditioned fearWei Wei, Carlos M Coelho, Xiang Li, et al.Plos One|February 15, 2023
Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptomsGiuseppe Alessio Platania, Claudia Savia Guerrera, Pierfrancesco Sarti, et al.Journal of Medicinal Chemistry|August 10, 2023
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) InhibitorAlessandra Feoli, Giulia Iannelli, Alessandra Cipriano, et al.BMC Psychiatry|November 29, 2023
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysisClaudia Savia Guerrera, Giuseppe Alessio Platania, Francesco Maria Boccaccio, et al.Oncotarget|October 6, 2017
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cellsEvelina Miele, Sergio Valente, Vincenzo Alfano, et al.Journal of Medicinal Chemistry|August 7, 2018
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation InhibitorsAnnachiara Gandini, Manuela Bartolini, Daniele Tedesco, et al.Diabetes|January 25, 2014
The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patientsMatteo Vecellio, Francesco Spallotta, Simona Nanni, et al.Pageof 15